In recent years, the financial landscape has seen a growing trend in the use of structured products or certificates as a tool for transferring insurance risk to investors.
More and more life and health insurance companies are addressing these products to retail investors, resulting in a burgeoning phenomenon in the insurance-linked securities (ILS) market.
We discuss the potential benefits and drawbacks of insurance-linked structured products, assess the validity of newcomer issuers, and evaluate the quality of investment proposals through these products.

Insurance-linked Structured Products: A New Frontier in Risk Transfer and Investment Opportunities.
Insurance-linked Structured Products: A New Frontier in Risk Transfer and Investment Opportunities.
Insurance-Linked Structured Products: A Primer
Structured products are financial instruments that combine various assets or derivatives to create a customized investment solution. Insurance-linked structured products (ILSPs) are a subset of structured products that involve the transfer of insurance risk to investors.
In essence, these products enable insurance companies to offload their liabilities to the capital markets, while offering investors a unique investment opportunity with potentially attractive returns.
Typically, ILSPs are issued as catastrophe bonds (cat bonds), longevity swaps, or other securities tied to insurance events. These products provide insurance companies with a source of capital to cover potential claims, while investors receive periodic payments or coupons based on the underlying insurance risks.
Insurance-linked structured products have emerged as a popular tool for transferring insurance risk to investors, particularly in the life and health insurance sectors.
These innovative financial instruments have gained traction among retail investors, who see them as an opportunity to diversify their investment portfolios and tap into the lucrative insurance market.
However, as this new phenomenon takes root, questions arise over the validity of newcomer issuers and the quality of their investment proposals.
Insurance-linked Structured Products: The Basics
Insurance-linked structured products, or certificates, are financial instruments that combine insurance and investment components.
They are designed to transfer insurance risk – primarily life and health risks – to investors by linking the product’s return to the performance of an underlying insurance portfolio. If the portfolio performs well, the investor enjoys higher returns, while underperformance results in lower returns or even a loss.
These products can take various forms, including catastrophe bonds (cat bonds), longevity bonds, or mortality bonds, depending on the type of insurance risk being transferred.
Cat bonds, for instance, are linked to natural disaster risks, while longevity bonds transfer the risk of policyholders living longer than expected. Mortality bonds, on the other hand, transfer the risk of policyholders dying earlier than anticipated.
Benefits of Insurance-Linked Structured Products
- Diversification: ILSPs offer investors an alternative asset class, which may have low or negative correlations with traditional investments such as stocks and bonds. This can help to diversify an investor’s portfolio, reducing overall risk.
- Attractive Returns: Given their risk profile, ILSPs tend to offer higher yields than traditional fixed-income securities. Additionally, returns on these products are typically less affected by interest rate fluctuations or macroeconomic factors, providing a stable source of income for investors.
- Customization: ILSPs can be tailored to meet the specific needs and risk preferences of investors, providing customized exposure to various insurance risks and return profiles.
- Risk Mitigation for Insurers: By transferring insurance risks to investors, insurers can better manage their capital and reduce the impact of large claims on their balance sheets.
Drawbacks of Insurance-Linked Structured Products
- Complexity: ILSPs are complex financial instruments that may be challenging for retail investors to understand fully. Investors should have a thorough understanding of the underlying risks and potential payouts before investing in these products. The inherent complexity can lead to a lack of transparency and increased risk of mis-selling.
- Limited Liquidity: Due to their niche nature, ILSPs may have limited liquidity in the secondary market, making it difficult for investors to sell their positions when needed. Unlike traditional bonds, insurance-linked structured products can be less liquid due to their niche nature, potentially making it more challenging for investors to exit their positions.
- Risk of Loss: Investors in ILSPs are exposed to the risk of loss if the underlying insurance event occurs. The magnitude of the loss depends on the severity of the event and the structure of the product.
- Counterparty Risk: As with any investment, investors in ILSPs face counterparty risk, which refers to the risk that the issuer (insurance company) may default on its payment obligations.
Basis risk
Investors in insurance-linked structured products may face basis risk, which occurs when the payout from the structured product does not perfectly match the investor’s actual loss experience. This can result from differences in the coverage provided by the product and the actual losses suffered by the investor.
Evaluating Newcomer Issuers and Investment Proposals
With the growing popularity of insurance-linked structured products, new issuers are entering the market. To assess the validity and stability of these newcomers, investors should consider the following factors:
- Financial Strength: Investigate the financial health of the issuer, including capital adequacy, liquidity, and credit ratings. A strong financial position reduces the likelihood of default and helps ensure that the issuer can meet its payment obligations.
- Track Record: Review the issuer’s experience in the insurance industry and its success in managing insurance risks. A proven track record can instill confidence in the issuer’s ability to effectively navigate the complexities of the market.
- Management Team: Evaluate the background, expertise, and experience of the management team, as strong leadership and a competent team are crucial for success in the insurance and financial sectors.
- Product Structure and Terms: Analyze the structure and terms of the investment proposal, ensuring that you fully understand the potential risks, rewards, and underlying insurance events. Be cautious of proposals that appear too good to be true or lack transparency.
Insurance-linked structured products offer a unique opportunity for retail investors to diversify their portfolios and access the insurance market.
However, these complex instruments come with potential drawbacks and risks that must be carefully considered.
As new issuers enter the market, investors should thoroughly evaluate the financial strength, track record, management team, and investment proposals of these newcomers to make informed decisions and mitigate potential risks.
Get Started with YiELDEN
